Health Care

Semaglutide Injections, IV Hydration, and the Visionaries at Drip Docx: Navigating the Next Generation of Wellness

Semaglutide Injections, IV Hydration, and the Visionaries at Drip Docx: Navigating the Next Generation of Wellness

​​Alexandria, VA - (NewMediaWire) - September 25, 2023 - As the health and wellness industry evolves, cutting-edge treatments like Semaglutide… Read More

23 hours ago

Neo-Bionica Appoints Uli Gommel As Chief Technology Officer

LOS ANGELES, Calif., Sept. 25, 2023 (SEND2PRESS NEWSWIRE) — Neo-Bionica, a leading innovator in the field of medical device development… Read More

1 day ago

Sharps Technology, Inc. CEO is Featured in an Interview with SmallCapsDaily

​​NEW YORK, NY - (NewMediaWire) - September 22, 2023 - Sharps Technology, Inc. (NASDAQ: STSS), is pleased to announce its… Read More

4 days ago

First-of-their-kind Brain Health scholarships announced in honor of Dr. Ralph Sacco

​​DALLAS and MINNEAPOLIS, Sept. 21, 2023 – In an effort to increase understanding, prevention and treatment of brain disease, the… Read More

5 days ago

GeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent Antibody and Cellular Immunity in Immunocompromised Patients

​​Data Published From Phase 2 Open-Label Study of GEO-CM04S1ATLANTA, GA - (NewMediaWire) - September 19, 2023 - GeoVax Labs, Inc. (Nasdaq:… Read More

1 week ago

iCoreConnect, Inc. Announces New Endorsement Partnership With the Rhode Island Dental Association Continuing Its Expansion Into New States

​​OCOEE, FL - (NewMediaWire) - September 19, 2023 -  iCoreConnect, Inc., (NASDAQ: ICCT), (“iCore” or the “Company”), a cloud-based software and… Read More

1 week ago

Job strain combined with high efforts and low reward doubled men’s heart disease risk

​​Research Highlights: Men exposed to stressful working conditions who also felt that they put forth high effort but received low… Read More

1 week ago

Timber Pharmaceuticals Announces NYSE Acceptance of Plan to Regain Listing Compliance

​​WARREN, NJ - (NewMediaWire) - September 18, 2023 - Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a clinical-stage… Read More

1 week ago

Emerging Trends in Biologics Research: From Bench to Bedside

Biologics have emerged as a groundbreaking class of pharmaceuticals, revolutionizing the field of medicine through targeted therapies. Unlike traditional small-molecule… Read More

1 week ago